H.R. 307 · 119th Congress · Health

ARC Act of 2025

In committee2.4k words Introduced Jan 9, 2025 · Latest action Jan 14, 2025

How far it has goneStage 2 of 6
  1. IntroducedJan 9, 2025 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill provides for coverage of peripheral artery disease screening tests without cost-sharing under Medicare and Medicaid for certain at-risk individuals. It also requires the development of certain educational programs, a payment model, and Medicare quality measures to reduce amputations relating to such disease.

Congressional Research Service · summary of “Introduced in House” version · Jan 9, 2025

Who lobbies on it

5 organizations · 31 filings · Q1 2025–Q3 2026

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Medtronic (cardiovascular Coalition) 7 of 7 quarters
    “Physician payment and policy issues related to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026”

    Q3 2026 filing · $3.7M lobbying spend in 2026 to date, all issues

  2. American College of Cardiology 7 of 7 quarters
    “Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for…”

    Q3 2026 filing · $1.9M lobbying spend in 2026 to date, all issues

  3. Cardiovascular Coalition 7 of 7 quarters
    “Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; H.R. 307 - ARC Act of 2025; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024; H.R. 9693 - Patients First Act of 2026”

    Q3 2026 filing · $360K lobbying spend in 2026 to date, all issues

2 more organizations, every filingPROUpgrade

Organizations that named H.R. 307 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

3 actions · newest first
  1. Jan 14, 2025Sponsor introductory remarks on measure. (CR H122)
  2. Jan 9, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. Jan 9, 2025Introduced in House